financetom
Personal Finance
financetom
/
Personal Finance
/
Empowering women: A deep dive into concept of nominations with financial experts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Empowering women: A deep dive into concept of nominations with financial experts
Nov 29, 2023 10:33 AM

Neha Pathak, Head of Trust & Estate Planning at Motilal Oswal Private Wealth, and Bijal Ajinkya, Partner at Khaitan & Co, on Wednesday, November 29, shed light on the role of nominations in managing assets, particularly in mutual funds and demat accounts.

Ajinkya clarified that a nominee doesn't hold ownership rights even after the original holder's passing. Instead, they act as trustees until the lawful heir is determined under succession laws. The discussion underscored the prevalent practice of hastily assigning nominees without due consideration. Ajinkya cautioned against this practice, advising alignment between nominees and heirs in wills to avoid potential disputes.

This conversation coincides with the ongoing discourse prompted by the Securities and Exchange Board of India (SEBI). SEBI has mandated all mutual fund investors to either furnish nomination declarations or opt out of nominations by December 31. Failure to comply with this deadline might result in SEBI freezing debits from investor holdings, effectively preventing withdrawals from mutual funds.

While existing investors who have previously provided nomination details are exempt from resubmitting, those who haven't yet submitted nominations must act promptly to avoid complications.

Nomination is important as it helps in transferring of assets to a nominated individual in the event of the investor's demise, thereby avoiding prolonged legal processes.

Pathak added clarity to the concept of nomination, defining it as a designation for a specific person concerning a particular asset or property. She emphasised the flexibility of nominations, allowing owners to modify nominees at their discretion. Additionally, Pathak differentiated between nominees and legal heirs, highlighting the significance of personal laws like the Hindu Succession Act and Sharia law in determining legal heirs.

"The law is crystal clear that the nominee isn't the owner," Pathak said, stressing the importance of having a will to avoid ambiguity regarding asset distribution.

Watch this video for more.

(Edited by : Anshul)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Hold Opinion On Shares Of Canada Goose
Research Alert: CFRA Maintains Hold Opinion On Shares Of Canada Goose
Aug 5, 2025
07:20 AM EDT, 08/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by USD1.00 to USD12.00, based on 15x our FY 26 (Mar.) EPS estimate and below the company's three-year average forward P/E multiple of 17.6x....
Research Alert: CFRA Maintains Sell Opinion On Adss Of Bp P.l.c.
Research Alert: CFRA Maintains Sell Opinion On Adss Of Bp P.l.c.
Aug 5, 2025
07:05 AM EDT, 08/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to USD23 (from USD20), based on a 2025 P/E of 8.3x, which reflects 0.5 SD below the 10-year average of 14.4x. Our EPS forecasts are...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Cenovus Energy
Research Alert: CFRA Keeps Buy Opinion On Shares Of Cenovus Energy
Aug 5, 2025
11:15 AM EDT, 08/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of CAD 24, up CAD 1, reflects a 4.8x multiple of EV to projected '26 EBITDA, in line with CVE's historical forward average. We cut our...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Pfizer Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Pfizer Inc.
Aug 5, 2025
11:10 AM EDT, 08/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After reviewing Q2 results, we maintain our target price at $28, 9.2x our 2026 EPS estimate, a discount to PFE's historical forward P/E average. We raise our 2025 EPS view...
Copyright 2023-2026 - www.financetom.com All Rights Reserved